An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
Elizabeth S. Klings, Mark T. Gladwin(University of Maryland, Baltimore), Roberto F. Machado(University of Maryland, Baltimore), Lewis L. Hsu, J. Simon R. Gibbs(National Institutes of Health), Claudia R. Morris, Oswaldo Castro, Laura DeCastro, Kenneth I. Ataga(University of Tennessee Health Science Center), Kevin C. Wilson(Unknown), Victor R. Gordeuk(University of Illinois Chicago), David B. Badesch(University of Colorado Anschutz Medical Campus), Lakshmanan Krishnamurti(Emory University), Marilyn J. Telen(Duke University), Martin H. Steinberg(Boston Medical Center), Gregory J. Kato(RED Consulting (Norway)), Namita Sood, Erika B. Rosenzweig(New York Medical College), Robyn J. Barst(Columbia University), Kamal K. Mubarak
Cited by 256
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Survival in Patients with Primary Pulmonary Hypertension
|Annals of Internal Medicine|1991|3.5k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k